Abstract:SCN–VAN connectivity may be an antidepressant target associated with depressive state changes and a predictor of treatment response to serotonin reuptake inhibitors. The within‐network hypoconnectivity in SCN and DMN may reflect a trait‐like abnormality in MDD. Lack of placebo control is a limitation of this study. In this study, the effects of antidepressants on large‐scale brain networks and the neural basis of individual differences in response were explored. A total of 41 patients with major depressive disorder (MDD) and 42 matched healthy controls (HCs) were scanned by resting‐state functional magnetic resonance imaging separately at baseline and after a 12‐week follow‐up. The patients with MDD received escitalopram for 12 weeks. After treatment, patients were classified into those with MDD in remission [MDDr, endpoint 17‐item Hamilton Depression Rating Scale (HAMD) total score ≤7] and those in nonremission (MDDnr). The human Brainnetome Atlas was used to define large‐scale networks and compute within‐ and between‐network resting‐state functional connectivity (rsFC). Results showed the decreased subcortical network (SCN)–ventral attention network (VAN) connectivity at baseline increased in patients with MDD after 12‐week treatment, and it was comparable with that of HCs. This change was only observed in patients with MDDr. However, the decreased within‐network rsFC in SCN and default mode network (DMN) persisted in all patients with MDD, including those with MDDr and MDDnr, after treatment. The strength of SCN–VAN connectivity at baseline was significantly negatively correlated with the reduction rate of HAMD score in all patients with MDD. Thus, SCN–VAN connectivity may be an antidepressant target associated with depressive state changes and a predictor of treatment response to serotonin reuptake inhibitors. The within‐network rsFC in SCN and DMN may reflect a trait‐like abnormality in MDD. These findings provide further insights into the mechanism of antidepressants and their individual differences in response. The trial name is "Appropriate technology study of MDD diagnosis and treatment based on objective indicators and measurement" (URL: http://www.chictr.org.cn/showproj.aspx?proj=21377; registration number: ChiCTR‐OOC‐17012566).

Duloxetine Effects on Striatal Resting-State Functional Connectivity in Patients with Major Depressive Disorder.

Effects of Antidepressant Treatment on Cognitive Control Network in Patients with Major Depressive Disorder

Abnormal Functional Connectivity of the Anterior Cingulate Cortex Subregions Mediates the Association Between Anhedonia and Sleep Quality in Major Depressive Disorder

Striatal Functional Connectivity Alterations after Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder

Functional connectivity between the habenula and posterior default mode network contributes to the response of the duloxetine effect in major depressive disorder

The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder.

Abnormal Striatum Functional Connectivity in Major Depressive Disorder: a Resting State Functional Magnetic Resonance Imaging Study

Reduced Nucleus Accumbens Functional Connectivity in Reward Network and Default Mode Network in Patients with Recurrent Major Depressive Disorder.

Modulation Effects of Repetitive Transcranial Magnetic Stimulation on Target and Indirect Target Nodes in Patients with Major Depressive Disorder

Decreased Functional Connectivity to Posterior Cingulate Cortex in Major Depressive Disorder

Effects of escitalopram therapy on effective connectivity among core brain networks in major depressive disorder

Differential Effects of Antidepressant Treatment on Long-Range and Short-Range Functional Connectivity Strength in Patients with Major Depressive Disorder

Aberrant Resting-State Functional Connectivity in MDD and the Antidepressant Treatment Effect—A 6-Month Follow-Up Study

A distinctive subcortical functional connectivity pattern linking negative affect and treatment outcome in major depressive disorder

Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder

Baseline Patterns of Resting Functional Connectivity Within Posterior Default-Mode Intranetwork Associated with Remission to Antidepressants in Major Depressive Disorder

Eight‐week antidepressant treatment reduces functional connectivity in first‐episode drug‐naïve patients with major depressive disorder

Different characteristics of striatal resting-state functional conectivity in treatment-resistant and non-treatment-resistant depression

Altered Effective Connectivity Within Default Mode Network in Major Depression Disorder

Eight-week Antidepressant Treatment Changes Intrinsic Functional Brain Topology in First-Episode Drug-Naïve Patients with Major Depressive Disorder

Decoupling of Dopamine Release and Neural Activity in Major Depressive Disorder during Reward Processing Assessed by Simultaneous fPET-fMRI